In 66 breast cancer biopsies, the expression of the Ca2+-binding protein S100A4, E-cadherin, α- and β-catenin was examined by immunohistochemistry, and the results were related to clinical and pathological parameters. This evidence concerns the gene CA2 and breast carcinoma.